DETERMINING THE VALUE OF OCREVUS (R) (OCRELIZUMAB) FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
No Thumbnail Available
Identifiers
Date
2018-10-01
Authors
Alerany, C.
Fernandez, R.
Landete, L.
Rodriguez, A.
Sandoval, S.
Valdivia, M.
Gil, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier science inc
Metrics
Export
